Key Highlights
•
A quality improvement project in pediatric diabetes care used simple changes like same-day scheduling and online booking to dramatically reduce the number of children lost to follow-up from 38% to just 15% over 18 months, a benefit that was sustained for over two years.
Source →
•
A new study found that lecanemab, an Alzheimer’s antibody, binds to amyloid-beta in the human brain in a way very similar to other antibodies, suggesting that its lower rate of brain swelling side effects is not due to a unique target. The study also showed that carrying the APOE ε4 gene variant is linked to having more antibody-accessible amyloid in the brain.
Source →
•
For early-stage testicular cancer, a new perspective suggests that doctors should prioritize treatment plans that achieve a cure with the least possible long-term side effects, rather than rushing to treat aggressively. This approach aims to maximize the patient’s quality of life after successful cancer treatment.
Source →
Stay curious. Stay informed — with
Science Briefing.
Always double check the original article for accuracy.
